{'fraction_non_alphanumeric': 0.04071661237785016, 'fraction_numerical': 0.006514657980456026, 'mean_word_length': 5.910112359550562, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
In vitro evaluation of the quality of blood products collected and stored in systems completely free of di(2‐ethylhexyl)phthalate–plasticized materials

The plasticizer di(2‐ethylhexyl)phthalate (DEHP) is a common component in blood bags. DEHP is noncovalently bound to polyvinylchloride (PVC) polymer and can leach into the blood product. There are public concerns that exposure to DEHP might induce developmental and reproductive toxicity in humans. The aim of this study was to evaluate an alternative plasticizer, di(isononyl) cyclohexane‐1,2‐dicarboxylate (Hexamoll DINCH, BASF SE), for its use in blood bags.